Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis

Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases

(2015) Akshal S. Patel et al.   Oncotarget

Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome

(2014) C. Muniz et al.   BLOOD

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma

(2014) W. H. Wilson et al.   HAEMATOLOGICA

Differences in cerebrospinal fluid inflammatory cell reaction of patients with leptomeningeal involvement by lymphoma and carcinoma

(2014) Julia Illán et al.   Translational Research

A Simplified Flow Cytometric Immunophenotyping Procedure for the Diagnosis of Effusions Caused by Epithelial Malignancies

(2013) Vinodh Pillai et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Use of TransFix™ cerebrospinal fluid storage tubes prevents cellular loss and enhances flow cytometric detection of malignant hematological cells after 18 hours of storage

(2013) Adriaan H. de Jongste et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors

(2013) L. Nayak et al.   NEUROLOGY

Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination

(2012) G. Benevolo et al.   BLOOD

Leptomeningeal Metastases

(2012) Jordi Bruna et al.   Current Treatment Options in Neurology

Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma

(2011) R. Alvarez et al.   ANNALS OF ONCOLOGY

An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions

(2011) Nektaria A. Kentrou et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Meningeal carcinomatosis in breast cancer: prognostic factors and outcome

(2011) Carla Rameri Alexandre Silva de Azevedo et al.   JOURNAL OF NEURO-ONCOLOGY

Survival of breast cancer patients with meningeal carcinomatosis

(2010) H. Gauthier et al.   ANNALS OF ONCOLOGY

Leptomeningeal metastasis

(2010) Marc C Chamberlain   CURRENT OPINION IN ONCOLOGY

Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin’s lymphoma patients at high risk of central nervous system disease in the rituximab era

(2010) Juan-Manuel Sancho et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Diagnosis and individualized therapy of neoplastic meningitis

(2010) Herwig Strik et al.   Expert Review of Anticancer Therapy

Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis

(2010) Karin Oechsle et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Epithelial-Mesenchymal Transition

(2009) Michael W. Klymkowsky et al.   AMERICAN JOURNAL OF PATHOLOGY

Neoplastic Meningitis–Related Prognostic Significance of the Karnofsky Performance Status

(2009) Marc C. Chamberlain et al.   ARCHIVES OF NEUROLOGY

Neoplastic meningitis

(2009) Marc C. Chamberlain et al.   CANCER

Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma

(2009) Morris D. Groves et al.   JOURNAL OF NEURO-ONCOLOGY

Leptomeningeal carcinomatosis

(2008) Jordi Bruna et al.   CANCER